SCHEMBL3033680

SCHEMBL3033680

NC(=O)c1ccc(-c2ccc(C(=O)N(O)Cc3ccccc3Cl)cc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.45
HIF1A Q16665 1/20 0.44
RORC P51449 1/20 0.43
LMNA P02545 1/20 0.40
MAP3K14 Q99558 1/20 0.40
P2RX7 Q99572 1/20 0.39
MKNK1 Q9BUB5 2/20 0.39
MKNK2 Q9HBH9 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TAS2R14 Q9NYV8 1/20 0.39
MAP2K4 P45985 1/20 0.39
MAP4K4 O95819 1/20 0.38
HTR3E A5X5Y0 1/20 0.38
HTR3B O95264 1/20 0.38
HTR3A P46098 1/20 0.38
HTR3D Q70Z44 1/20 0.38
HTR3C Q8WXA8 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3453588 0.83 GRIN1 (0.46) POLBLMNAMAP3K14MEN1KMT2A
SCHEMBL3018071 0.80 PLA2G10 (0.53) POLBRORCMKNK1MKNK2MEN1
SCHEMBL27547473 0.76 PARP10 (0.57) LMNAMEN1KMT2AHPGDPKM
SCHEMBL11009282 0.71 PYCR1 (0.46) MEN1KMT2ATAS2R14ALDH1A1
SCHEMBL4777536 0.70 GAA (0.58) POLBRORCLMNAMEN1KMT2A
SCHEMBL16584861 0.69 PNMT (0.58) POLBSMN1; SMN2HIF1ALMNAMAP3K14
SCHEMBL2688812 0.69 CHEK2 (0.58) POLBMKNK1MKNK2MAP2K4MAP4K4
SCHEMBL3036832 0.68 HPGD (0.57) POLBSMN1; SMN2LMNAMKNK1MKNK2
SCHEMBL30765134 0.68 SMN1; SMN2 (0.62) POLBSMN1; SMN2HIF1ALMNAMAP3K14
SCHEMBL30765129 0.68 NR4A2 (0.75) POLBMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS KATTAR SOLOMON 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216796-A1 N-HYDROXY-NAPHTHALENE DICARBOXAMIDE AND N-HYDROXY-BIPHENYL-DICARBOXAMIDE COMPOUNDS AS HISTONE DEACETYLASE INHIBITORS BRDT, AADAC, ACIN1 POLB 3269/4885SMN1; SMN2 921/4885HIF1A 793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.